146 related articles for article (PubMed ID: 8394364)
21. Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes.
Kasukabe T; Okabe-Kado J; Hozumi M; Honma Y
Cancer Res; 1994 Jan; 54(2):592-7. PubMed ID: 8275499
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer.
Watson PH; Pon RT; Shiu RP
Cancer Res; 1991 Aug; 51(15):3996-4000. PubMed ID: 1855215
[TBL] [Abstract][Full Text] [Related]
23. C-myc expression affects proliferation but not terminal differentiation or survival of explanted erythroid progenitor cells.
Bondurant MC; Yamashita T; Muta K; Krantz SB; Koury MJ
J Cell Physiol; 1996 Aug; 168(2):255-63. PubMed ID: 8707861
[TBL] [Abstract][Full Text] [Related]
24. The c-myc gene regulates the polyamine pathway in DMSO-induced apoptosis.
Trubiani O; Pieri C; Rapino M; Di Primio R
Cell Prolif; 1999; 32(2-3):119-29. PubMed ID: 10535358
[TBL] [Abstract][Full Text] [Related]
25. Glucocorticoid, interleukin-2, and prostaglandin interactions in a clonal human leukemic T-cell line.
Johnson BH; Dean RR; Moran SM; Thompson EB
J Steroid Biochem Mol Biol; 1992 Mar; 42(1):1-9. PubMed ID: 1558815
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.
Carroll JS; Swarbrick A; Musgrove EA; Sutherland RL
Cancer Res; 2002 Jun; 62(11):3126-31. PubMed ID: 12036924
[TBL] [Abstract][Full Text] [Related]
27. Antisense c-myc effects on preimplantation mouse embryo development.
Paria BC; Dey SK; Andrews GK
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10051-5. PubMed ID: 1279668
[TBL] [Abstract][Full Text] [Related]
28. Enhanced susceptibility of c-myc antisense oligonucleotide-treated human renal cell carcinoma cells to lysis by peripheral blood lymphocytes.
Mizutani Y; Bonavida B; Fukumoto M; Yoshida O
J Immunother Emphasis Tumor Immunol; 1995 Feb; 17(2):78-87. PubMed ID: 7647959
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration.
Biro S; Fu YM; Yu ZX; Epstein SE
Proc Natl Acad Sci U S A; 1993 Jan; 90(2):654-8. PubMed ID: 8421701
[TBL] [Abstract][Full Text] [Related]
30. Psoralen-modified clamp-forming antisense oligonucleotides reduce cellular c-Myc protein expression and B16-F0 proliferation.
Stewart DA; Thomas SD; Mayfield CA; Miller DM
Nucleic Acids Res; 2001 Oct; 29(19):4052-61. PubMed ID: 11574688
[TBL] [Abstract][Full Text] [Related]
31. Quantifying c-myc expression in c-myc antisense phosphorothioate oligodeoxynucleotide-treated leukemic and colon cancer cell lines.
Li BD; Budnick RM; Russo CA; Anderson GR; Stewart CC
J Surg Res; 1995 Oct; 59(4):485-92. PubMed ID: 7564322
[TBL] [Abstract][Full Text] [Related]
32. Modulation of c-myc transcription by triple helix formation.
Postel EH
Ann N Y Acad Sci; 1992 Oct; 660():57-63. PubMed ID: 1340156
[TBL] [Abstract][Full Text] [Related]
33. Nuclear c-Myc plays an important role in the cytotoxicity of tumor necrosis factor alpha in tumor cells.
Jänicke RU; Lee FH; Porter AG
Mol Cell Biol; 1994 Sep; 14(9):5661-70. PubMed ID: 8065303
[TBL] [Abstract][Full Text] [Related]
34. Glucocorticoid modulation of transformed cell proliferation is oncogene specific and correlates with effects on c-myc levels.
O'Banion MK; Levenson RM; Brinckmann UG; Young DA
Mol Endocrinol; 1992 Sep; 6(9):1371-80. PubMed ID: 1331773
[TBL] [Abstract][Full Text] [Related]
35. Myc protein is differentially sensitive to quinidine in tumor versus immortalized breast epithelial cell lines.
Melkoumian ZK; Martirosyan AR; Strobl JS
Int J Cancer; 2002 Nov; 102(1):60-9. PubMed ID: 12353235
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of c-myc expression by antisense oligonucleotides inhibits proliferation of human smooth muscle cells.
Shi Y; Hutchinson HG; Hall DJ; Zalewski A
Circulation; 1993 Sep; 88(3):1190-5. PubMed ID: 8353880
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional regulation of the interleukin 2 gene by glucocorticoid hormones. Role of steroid receptor and antigen-responsive 5'-flanking sequences.
Vacca A; Martinotti S; Screpanti I; Maroder M; Felli MP; Farina AR; Gismondi A; Santoni A; Frati L; Gulino A
J Biol Chem; 1990 May; 265(14):8075-80. PubMed ID: 2159467
[TBL] [Abstract][Full Text] [Related]
38. Quantification and glucocorticoid regulation of glucocorticoid receptor transcripts in two human leukemic cell lines.
Pedersen KB; Vedeckis WV
Biochemistry; 2003 Sep; 42(37):10978-90. PubMed ID: 12974633
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of sensitivity of urinary bladder tumor cells to cisplatin by c-myc antisense oligonucleotide.
Mizutani Y; Fukumoto M; Bonavida B; Yoshida O
Cancer; 1994 Nov; 74(9):2546-54. PubMed ID: 7923012
[TBL] [Abstract][Full Text] [Related]
40. Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor.
Helmberg A; Auphan N; Caelles C; Karin M
EMBO J; 1995 Feb; 14(3):452-60. PubMed ID: 7859735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
